Copyright © 2005, European Society of Cardiology
Regulation of cardiac contractile function by troponin I phosphorylation
aCardiovascular Division, King's College, London SE5 9PJ, UK
bUniversity of Illinois at Chicago, IL, United States
* Corresponding author. Department of Cardiology, GKT School of Medicine, Bessemer Road, London SE5 9PJ, UK. Tel.: +44 207 3463865; fax: +44 207 3464771. Email address: ajay.shah{at}kcl.ac.uk
Cardiac troponin I (cTnI) is a key regulatory protein in cardiac muscle contraction and relaxation, linking Ca2+–troponin C binding with activation of crossbridge reactions with the thin filament. In recent years, it has become increasingly apparent that myofilament properties as well as changes in intracellular Ca2+have a major role in the dynamic modulation of contractile function. The phosphorylation of specific serine and threonine residues on cTnI by several different kinases represents a major physiological mechanism for alteration of myofilament properties. Furthermore, altered thin filament function plays an important role in the contractile dysfunction associated with heart failure. Modification of cTnI by protein kinases A and C has been extensively studied with especially useful information deriving from (a) in vitro studies in reconstituted detergent-skinned fibre bundles in which endogenous cTnI was replaced with various targeted cTnI mutants and (b) transgenic animals in which endogenous cTnI was similarly manipulated through overexpression of cardiomyocyte-targeted cTnI mutants. cTnI may also be specifically modified by protein kinase G, p21-activated kinases and by dephosphorylation. This review focuses on recent advances in understanding the mechanisms of cTnI modification by these kinases and the consequent functional effects both under physiological conditions and in pathophysiological settings.
KEYWORDS Myocardial contractility; Troponin I; Phosphorylation; Protein kinases
Time for primary review 25 days
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  O. Cazorla, A. Lucas, F. Poirier, A. Lacampagne, and F. Lezoualc'h The cAMP binding protein Epac regulates cardiac myofilament function PNAS, August 18, 2009; 106(33): 14144 - 14149. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. J. Guinto, T. E. Haim, C. C. Dowell-Martino, N. Sibinga, and J. C. Tardiff Temporal and mutation-specific alterations in Ca2+ homeostasis differentially determine the progression of cTnT-related cardiomyopathies in murine models Am J Physiol Heart Circ Physiol, August 1, 2009; 297(2): H614 - H626. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Matsuba, T. Terui, J. O-Uchi, H. Tanaka, T. Ojima, I. Ohtsuki, S. Ishiwata, S. Kurihara, and N. Fukuda Protein kinase A-dependent modulation of Ca2+ sensitivity in cardiac and fast skeletal muscles after reconstitution with cardiac troponin J. Gen. Physiol., June 1, 2009; 133(6): 571 - 581. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Marshall, N. Anilkumar, J. Layland, S. J. Walker, J. C. Kentish, A. M. Shah, and A. C. Cave Protein phosphatase 2A contributes to the cardiac dysfunction induced by endotoxemia Cardiovasc Res, April 1, 2009; 82(1): 67 - 76. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V. Zabrouskov, Y. Ge, J. Schwartz, and J. W. Walker Unraveling Molecular Complexity of Phosphorylated Human Cardiac Troponin I by Top Down Electron Capture Dissociation/Electron Transfer Dissociation Mass Spectrometry Mol. Cell. Proteomics, October 1, 2008; 7(10): 1838 - 1849. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. M. MacDonnell, G. Garcia-Rivas, J. A. Scherman, H. Kubo, X. Chen, H. Valdivia, and S. R. Houser Adrenergic Regulation of Cardiac Contractility Does Not Involve Phosphorylation of the Cardiac Ryanodine Receptor at Serine 2808 Circ. Res., April 25, 2008; 102(8): e65 - e72. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. P. Gupta, S. A. Samant, S. H. Smith, and S. G. Shroff HDAC4 and PCAF Bind to Cardiac Sarcomeres and Play a Role in Regulating Myofilament Contractile Activity J. Biol. Chem., April 11, 2008; 283(15): 10135 - 10146. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Liang, F. Chung, Y. Qu, D. Pavlov, T. E. Gillis, S. B. Tikunova, J. P. Davis, and G. F. Tibbits Familial hypertrophic cardiomyopathy-related cardiac troponin C mutation L29Q affects Ca2+ binding and myofilament contractility Physiol Genomics, April 1, 2008; 33(2): 257 - 266. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W.-J. Dong, J. Xing, Y. Ouyang, J. An, and H. C. Cheung Structural Kinetics of Cardiac Troponin C Mutants Linked to Familial Hypertrophic and Dilated Cardiomyopathy in Troponin Complexes J. Biol. Chem., February 8, 2008; 283(6): 3424 - 3432. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. E. Stelzer, J. R. Patel, J. W. Walker, and R. L. Moss Differential Roles of Cardiac Myosin-Binding Protein C and Cardiac Troponin I in the Myofibrillar Force Responses to Protein Kinase A Phosphorylation Circ. Res., August 31, 2007; 101(5): 503 - 511. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. A. Ramirez-Correa and A. M. Murphy Is Phospholamban or Troponin I the "Prima Donna" in -Adrenergic Induced Lusitropy? Circ. Res., August 17, 2007; 101(4): 326 - 327. [Full Text] [PDF]
|
|
|
|
 |
|
 T. Dai, Y. Tian, C. G. Tocchetti, T. Katori, A. M. Murphy, D. A. Kass, N. Paolocci, and W. D. Gao Nitroxyl increases force development in rat cardiac muscle J. Physiol., May 1, 2007; 580(3): 951 - 960. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Neulen, N. Blaudeck, S. Zittrich, D. Metzler, G. Pfitzer, and R. Stehle Mn2+-dependent protein phosphatase 1 enhances protein kinase A-induced Ca2+ desensitisation in skinned murine myocardium Cardiovasc Res, April 1, 2007; 74(1): 124 - 132. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Cuello, S. C. Bardswell, R. S. Haworth, X. Yin, S. Lutz, T. Wieland, M. Mayr, J. C. Kentish, and M. Avkiran Protein Kinase D Selectively Targets Cardiac Troponin I and Regulates Myofilament Ca2+ Sensitivity in Ventricular Myocytes Circ. Res., March 30, 2007; 100(6): 864 - 873. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. L. Engel, T. Kobayashi, B. Biesiadecki, J. Davis, S. Tikunova, S. Wu, and R. J. Solaro Identification of a Region of Troponin I Important in Signaling Cross-bridge-dependent Activation of Cardiac Myofilaments J. Biol. Chem., January 5, 2007; 282(1): 183 - 193. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. C. Bilchick, J. G. Duncan, R. Ravi, E. Takimoto, H. C. Champion, W. D. Gao, L. B. Stull, D. A. Kass, and A. M. Murphy Heart failure-associated alterations in troponin I phosphorylation impair ventricular relaxation-afterload and force-frequency responses and systolic function Am J Physiol Heart Circ Physiol, January 1, 2007; 292(1): H318 - H325. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. L. Granzier and K. B. Campbell New Insights in the Role of Cardiac Myosin Binding Protein C As a Regulator of Cardiac Contractility Circ. Res., October 13, 2006; 99(8): 795 - 797. [Full Text] [PDF]
|
|
|
|
 |
|
 A. El-Armouche, P. Boknik, T. Eschenhagen, L. Carrier, M. Knaut, U. Ravens, and D. Dobrev Molecular Determinants of Altered Ca2+ Handling in Human Chronic Atrial Fibrillation Circulation, August 15, 2006; 114(7): 670 - 680. [Abstract] [Full Text] [PDF]
|
|